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SUMMARY
Extended-spectrum β-lactamases (ESBL) in enterobacteria are recognized worldwide as a great hospital problem. In this study, 127 
ESBL-producing Enterobacteriaceae isolated in one year from inpatients and outpatients at a public teaching hospital at São Paulo, 






 genes. From the 127 isolates, 96 (75.6%) 
Klebsiella pneumoniae, 12 (9.3%) Escherichia coli, 8 (6.2%) Morganella morganii, 3 (2.3%) Proteus mirabilis, 2 (1.6%) Klebsiella 
oxytoca, 2 (1.6%) Providencia rettgeri, 2 (1.6%) Providencia stuartti, 1 (0.8%) Enterobacter aerogenes and 1 (0.8%) Enterobacter 






 were detected in 63%, 17.3% and 33.9% strains, respectively. 
Pulsed field gel eletrophoresis genotyping of K. pneumoniae revealed four main molecular patterns and 29 unrelated profiles. PCR 
results showed a high variety of ESBL groups among strains, in nine different species. The results suggest the spread of resistance 
genes among genetically different strains of ESBL-producing K. pneumoniae in some hospital wards, and also that some strongly 
related strains were identified in different hospital wards, suggesting clonal spread in the institutional environment.
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INTRODUCTION
Extended-spectrum beta-lactamases (ESBL) production by 
nosocomial pathogens are a major challenge for infection control 
committees in hospitals all over the world, once ESBL-producing strains 
and their encoding genes can stay permanently in hospitals, causing 
outbreaks and colonization (BRADFORD 2001, GUPTA et al. 2003, 
DENTON 2007). There are more than 300 ESBL described so far, most 
of them derived from groups TEM, SHV and CTX-M, with 150, 88 and 
69 variants, respectively (see http://www.lahey.org/Studies). 
In Latin America there is a high rate of ESBLs, although their 
distribution is still restricted to some genes and to specific locations 
(VILLEGAS et al. 2008). In SHV group, the variants SHV-2, SHV-5 and 
SHV-12 are the most common (PATERSON et al. 2003, VILLEGAS 
et al. 2008), although in Brazil there have already been reported the 
detection of SHV-4 (MENDES et al. 2004) and the characterization of 
SHV-27 (CORKILL et al. 2001). TEM variants have been described very 
recently in South America (PATERSON et al. 2003, VIGNOLI et al. 2005, 
VILLEGAS et al. 2008), and the most common are TEM-10, TEM-12 
and TEM-26 (VILLEGAS et al. 2008). CTX-M ESBLs are endemic and 
widely distributed in our continent. They were reported in 1989 in Argentina 
(CTX-M-2) and, since then, several different enzymes from this group 
were reported in many countries, including Brazil, where CTX-M-8, -9 
and -16 were described (VILLEGAS et al. 2008). Some recent Brazilian 
studies show the high prevalence of ESBL-carrying Enterobacteriaceae 
in healthcare centers and even in the community, especially in Klebsiella 
pneumoniae isolates (NOGUEIRA et al. 2006, MINARINI et al. 2007, 
MINARINI et al. 2008, SILVA DIAS et al. 2008). 
The aim of this study was to identify groups of ESBL disseminated 
among enterobacteria isolated during one year in a teaching hospital, as 
well as to establish the genetic relationship among all ESBL-producing 
K. pneumoniae isolates. 
MATERIAL AND METHODS
Setting: This study was carried out in a general public university 
hospital with 258 beds distributed among ten wards (Emergence Room 
- ER, Surgical Ward - SW, General Ward - AMW, Pediatric Ward - PW, 
Adult, Neonatal and Pediatric Intensive Care Units - A.ICU, N.ICU and 
P.ICU, Intermediate Care Unit - IMC, Neonatal Ward - NW and Maternity 
Ward - MW), with a mean turnover of 5500 patients-day/month. 
Bacterial strains: During one year, 127 ESBL-producing Entero-
bacteriaceae strains were recovered from clinical samples of hospitalized 
patients. Isolates were responsible for community- or hospital-acquired 
infections, and for colonization. 
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 Antimicrobial susceptibility profiles for K. pneumoniae PFGE patterns, with respective PCR results
PFGE n FOX CTX CAZ FEP ATM IPM SAM TZP TIM AMK GEN CIP SXT PCR (bla)






B* 14 S Ra R Sb R S R Ra R S Ra S Ra
SHV 
None




E 5 S R S R R S R R R S R S S
CTX-M 
SHV+CTX-M







a More than 50% of strains expressing resistance to the referred antibiotic; b More than 50% of strains expressing susceptibility to the referred antibiotic; n: number of 
strains; FOX: Cefoxitin; CTX: Cefotaxime; CAZ: Ceftazidime; FEP: Cefepime; ATM: Aztreonam; SAM: Ampicillin/Sulbactam; TZP: Piperacillin/Tazobactam; TIM: 
Ticarcillin/clavulanic acid; AMK: Amikacin; GEN: Gentamicin; CIP: Ciprofloxacin; SXT: Trimethoprim/sulfamethoxazole.
Susceptibility test and ESBL production: Antimicrobial susceptibility 
tests, screening and confirmatory tests for ESBL production were carried 
out in Vitek System (BioMerieux, Hazlewood, MO). Double-disk synergy 
(Oxoid, Cambridge, UK) was also performed as a confirmatory test for 
all positive isolates (CLSI 2008).
Detection of bla genes: Total DNA extraction was carried out for 
all samples using the heat-shock technique (CHAPMAN et al. 2001). 
Isolates were tested by PCR for the β-lactamase groups SHV, TEM 
and CTX-M, with previously described oligonucleotides and reaction 
conditions (CAO et al. 2002). PCR products were analyzed by agarose 
gel electrophoresis. 
Pulsed Field Gel Electrophoresis (PFGE): All K. pneumoniae 
isolates were submitted to DNA extraction (CDC 2004) and restriction 
endonuclease digestion with 10U XbaI. Separation of fragments was 
carried out at 6V/cm at 14 °C for 20h. The linear pulse time was 3,51s 
to 30,82s. Band polymorphism generated by PFGE was analyzed and 
the molecular patterns were grouped primarily according to previously 
established criteria (TENOVER et al. 1995), and then according to Dice 
similarity coefficient and demonstrated graphically in dendrograms. 
PFGE patterns were also analyzed according to their distribution among 
hospital wards during the studied period, using the software Pajek as a 
tool (BATAGELJ and MRVAR 1996).
RESULTS
Bacterial strains: 127 ESBL-producing isolates were recovered 
from 86 patients among all hospital wards, except for the Maternity. 
Ninety-six (75.6%) strains were K. pneumoniae (ESBL-Kp), 12 (9.3%) 
Escherichia coli, 8 (6.2%) Morganella morganii, 3 (2.3%) Proteus 
mirabilis, 2 (1.6%) Klebsiella oxytoca, 2 (1.6%) Providencia rettgeri, 
2 (1.6%) Providencia stuartti, 1 (0.8%) Enterobacter aerogenes and 1 
(0.8%) Enterobacter cloacae. According to the hospital infection control 
committee, 29 (22.8%) isolates were responsible for hospital-acquired 
infections, 14 (11%) for community-acquired infections, and 84 (66.1%) 
for cases of colonization, from which 57 (67.9%) were recovered from 
routine samples and 27 (32.1%) were from surveillance cultures carried 
out by the committee. 
Antimicrobial susceptibility tests and detection of ESBL 
production and genes: All strains were resistant to ampicillin and 
cephalotin, and susceptible to imipenem. Except for these results, 
the predominant antimicrobial susceptibility profiles for each PFGE 
pattern of K. pneumoniae strains are shown in Table 1, and for the other 
Enterobacteriaceae isolates are in Table 2. The combined discs method 
was able to detect the production of ESBL in all strains. 
PCR: Genes bla
SHV
 were detected in 80 (63%) isolates, bla
CTX-M
 in 43 
(33.9%) and bla
TEM
 in 22 (17.3%). Among K. pneumoniae, bla
SHV
 genes 
were detected in 71 (74%) strains. Twenty one (16.5%) strains produced 
some type of ESBL that could not be detected in PCR reactions, and 
thus were not classified as any of the groups studied. It was observed the 
detection of one to three groups of bla genes in each ESBL-producing 
isolate. All combinations of bla genes detected are shown in Tables 1 
and 2.
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Antimicrobial susceptibility profiles for other Enterobacteriaceae, with respective PCR results
Species (n) FOX CTX CAZ FEP ATM SAM TZP TIM AMK GEN CIP SXT PCR (bla)
Escherichia coli (12)
S S R S R R R R S S S S
SHV
S R R S R R S R S R R S
S S R S R R S R S R S S SHV+TEM
S R S R R R S S S S S R SHV+CTX-M
S R S R R R R R S S R R
TEM+CTX-M
S R R R R R R R S R R R
S R S R R R R R S R S R
CTX-M
S R S R R R S R S R R R
S R S R R R S S S R S S
S R S R R R S S S R S S
S R S S R R S S S S S R
None
S S R S R R S R S R R S
Morganella morgani (7)
R S S S S R S R S R R S SHV
R R S S S R S R S S R S SHV+CTX-M
R R S S S S S R S R R R
CTX-MR S S S S R S R S R R S
R R S S S R S S R R R R
R S S S S R S R S R R S
None
S S S S S R S R S S R R
Proteus mirabilis (4)
S S R S S R S S S R R R SHV
S S S S S R S S S R R R CTX-M
S S S R S R S R S R R R TEM+CTX-M
S S S S S S S S S R R R SHV+TEM+CTX-M
Providencia stuartii (2)
S R S R S R S R S R R S
CTX-M
S R S S S R S R S R R R
Klebsiella oxytoca (2)
S S S S S R S R R R S R TEM
S R S R R R R R R R R R CTX-M
Providencia rettgeri (1) S S S S S R S S R R R R None
Enterobacter cloacae (1) R S S S S S I S S S S S SHV+CTX-M
Enterobacter aerogenes (1) R R S R I R R R R I R R CTX-M
n: number of strains; AMP: Ampicillin; CEF: Cefalotin; FOX: Cefoxitin; CTX: Cefotaxime; CAZ: Ceftazidime; FEP: Cefepime; ATM: Aztreonam; IPM: Imipe-
nem; SAM: Ampicillin/Sulbactam; TZP: Piperacillin/Tazobactam; TIM: Ticarcillin/clavulanic acid; AMK: Amikacin; GEN: Gentamicin; CIP: Ciprofloxacin; SXT: 
Trimethoprim/sulfamethoxazole.
PFGE: Four main PFGE patterns (A, B, C and E) and four subtypes 
(A1, A3, A4 and B1) were obtained from 67 (69.8%) ESBL-Kp isolates 
(Fig. 1). The subtypes were classified according to previously established 
interpreting criteria (TENOVER et al. 1995). The other 29 (30.2%) 







 were grouped and called only A*, and pattern B and subtype B1 were 
called only B*. Pattern A* was observed in 33 (34.4%) strains, pattern 
B* in 14 (14.6%) strains, pattern C in 15 (15.6%) strains, and pattern 
E in five (5.2%) strains. The distribution of the different PFGE patterns 
among the hospital wards during the studied period is shown in Fig. 2. 
From isolates showing genetically related profiles, 53 (79.1%) were 
responsible for colonizations. For this group detection of bla
SHV
 genes was 
observed in 56 (83.6%) of 67 strains, bla
TEM
 in five (7.5%) and bla
CTX-M
 
in seven (10.4%) isolates. In strains showing unrelated patterns (29), it 
was possible to observe detection of bla
SHV
 genes in 22 (75.9%), bla
TEM
 
in 11 (37.9%) and bla
CTX-M
 in 16 (55.2%) strains. 
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Fig. 2 - Overall clone-sharing relationships among ESBL-Kp PFGE patterns, according to the hospital locations and the periods of isolation. A*, B*, C and E correspond to the PFGE related 
patterns. Small black spots are the 29 non-related patterns generated by PFGE. Arrows indicate the trajectory of each pattern during the studied period.
DISCUSSION
Production of ESBL has been frequently described worldwide, in 
several Enterobacteriaceae species, isolated from diverse clinical samples 
(QUINTEROS et al. 2003, CELENZA et al. 2006). In the present study, 
during one year it was detected one to three ESBL encoding genes (bla) 
in 127 isolates of nine Enterobacteriaceae species. It was not possible to 
establish the relationship among the several antimicrobial susceptibility 
patterns observed with the bla genes detected, once we carried out only a 
group identification. In regard to PFGE patterns, each of them presented 
a predominant susceptibility profile, although they had different bla 
genes combinations.
All the three groups of genes searched by PCR were detected, alone 
or in several combinations. Encoding genes for the SHV family were 
detected in 63% of the isolates, in six different species, from which 
88.7% were K. pneumoniae. Most enzymes from this group are ESBL, 
except for SHV-1 and SHV-11, and according to the literature most K. 
pneumoniae strains posses the chromosomal gene bla
SHV-1
 (BABINI 
& LIVERMORE 2000, HOWARD et al. 2002, LIVERMORE 2008). 
Hence, the identification of bla
SHV
 genes in the major part of ESBL-Kp 
strains in this study was already expected, although we cannot affirm 
those are ESBL-encoding genes, mostly in strains presenting more than 
one bla gene. On the other hand, bla
SHV
 genes were also detected in other 
four species (E. coli, M. morganii, P. mirabilis and E. cloacae), what 
Fig. 1 - Estimates of genetic relationship, according to Dice similarity coefficient, of XbaI 
patterns obtained for ESBL-producing K. pneumoniae strains isolated from clinical and 
surveillance samples of patients in the university hospital. On the left are quoted the PFGE 
profiles identified and on the right the numbers of isolates (*n) exhibiting each PFGE pattern.
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shows their spread potential among different strains. Group TEM was 
identified in 17.3% of isolates in five different species (K. pneumoniae, 
K. oxytoca, E.coli, M. morganii and P. mirabilis), generally in association 
with SHV and/or CTX-M genes. Therefore, it was not possible to 
presume if they were responsible for the ESBL phenotype or not, once 
they could be non-ESBL encoding genes associated to another gene 
expressing the extended-spectrum phenotype (LIVERMORE 2008). On 
the other hand, co-production of different ESBLs by a unique strain is 
a common finding in several studies (LI et al. 2003, PATERSON et al. 
2003, VIGNOLI et al. 2005, MINARINI et al. 2007), so the carriage of 
two or three ESBL encoding genes by the TEM-producing strains of our 
study could also have happened. CTX-M ESBL was detected in 33.9% 
of isolates, in all species, except for P. rettgeri. This emerging group of 
enzymes is prevalent and endemic in South America (CELENZA et al. 
2006, VILLEGAS et al. 2008) and, similarly to our work, some other 
studies in Argentina and Bolivia reported the finding of bla
CTX-M
 genes 
in a great variety of Enterobacteriaceae species (QUINTEROS et al. 
2003, CELENZA et al. 2006). ESBL-producing isolates in which none 
of the genes searched was detected could be carrying genes from other 
groups of extended-spectrum enzymes.
Klebsiella pneumoniae was the species with the highest number of 
isolates (75.6%) in this study. It is the most frequent ESBL-producing 
species, especially in Latin America, and its prevalence in Brazil is 
around 50%, while in the United States it is 5% and in Europe, 15 to 
20% (SADER et al. 2001, GALES et al. 2002, NOGUEIRA et al. 2006, 
VILLEGAS et al. 2008). As a nosocomial pathogen, it can cause severe 
morbidity and mortality in hospitalized patients, and once it is part of 
intestinal flora, rectal colonization can be strongly associated to infection 
by ESBL- Kp (GUPTA et al. 2003). In addition to its intrinsic resistance 
to ampicillin due to the presence of chromosomal β-lactamase SHV-1 
(BABINI & LIVERMORE 2000), it can also express resistance due to 
other β-lactamase classes like metalloenzymes and AmpC, and/or due to 
porine losses (MENDES et al. 2004, LINCOPAN et al. 2005, DENTON 
2007). In Brazil, there are some reports of multi-drug resistant hospital-
acquired K. pneumoniae (MENDES et al. 2004, LINCOPAN et al. 2005, 
PEIRANO et al. 2009). In the present study, four main PFGE patterns 
(A*, B*, C, and E) were obtained from 67 (69.8%) ESBL-Kp isolates. 
Figure 2 shows the distribution of all patterns among the hospital wards 
during the studied period, emphasizing that there was clearly four groups 
of genetically related strains and several isolated strains with genetic 
unrelated profiles. Patterns A* and B* were found mostly in the neonatal 
ward, neonatal ICU (B only) and pediatric ICU (A only), where a few 
unrelated patterns were identified (Fig. 2). These wards have patients 
with fragile host defenses, receiving excessive manipulation and a high 
antimicrobial intake, which could have been the predisposing factors for 
infections and spread of resistance genes (BRADFORD 2001, GUPTA 
et al. 2003). An outbreak took place in the Neonatal Ward during our 
study, and it is described elsewhere (CASSETARI et al. 2009). In Figure 
2 we can see that pattern A* was isolated from June 2004 to January 
2005, and pattern B* from December 2004 to February 2005. The 
“substitution” of pattern A* by B* in the neonatal ward was coincident 
with the infection control measures that were reinforced by the institution 
during the outbreak investigation. Although pattern C was identified in 
15 strains, seven of them were isolated from a unique patient who was 
hospitalized in Neonatal ICU, Pediatric ICU and Pediatric Ward during all 
the study period (data not shown) (Fig. 2). Pattern E was identified in three 
strains from patients of Neonatal Ward and in two strains from patients 
of Pediatric ICU, between November and December of 2004. After this 
period, no more strains from this pattern were isolated until the end of 
the study period (July of 2005) (Fig. 2). K. pneumoniae isolated from 
samples of patients from Adult ICU, IMC, General and Surgical wards, 
showed only unrelated patterns (Fig. 2). According to another study, when 
isolates are genetically distinct, the group of resistant microorganisms 
can be originated due to excessive antimicrobial selective pressure, which 
favors resistant phenotypes within an unrelated group of strains, turning 
to be a problem of endemic resistance of different groups of organisms 
(TOSIN et al. 2003). Also, approximately 30% of those unrelated strains 
were isolated from patients who had been transferred from other hospitals 
or had previous hospital stays in our institution. In other reports, after 
genotyping K. pneumoniae isolates, it was detected several distinct 
patterns, suggesting horizontal transfer of resistance genes as a way 
of spread. Those strains contained bla
CTX-M
 genes, which is exclusively 
located in mobile elements (LI et al. 2003, MINARINI et al. 2007). 
Similarly, in our study bla
CTX-M
 genes were detected in a high number of 
isolates with unrelated molecular patterns (55.2%), and in a few strains 
of patterns A*, B*, C and E, what can suggest that in the environment of 
the studied institution there was also the spread of these resistance genes 
by conjugation. Some other observations in our results can reaffirm this 
kind of spread. TEM ESBLs were not detected in isolates from pattern 
A, but they were present in the subtype A1, which had one extra band in 
relation to A. The same occurred for subtypes A3 and A4, in which groups 
TEM and CTX-M were present only in the last one, what could have 
happened due to the presence of different plasmids among the isolates (LI 
et al. 2003). Despite the wide spread of ESBL encoding genes through 
plasmids, the high genetic variability found among Brazilian strains 
suggests that a continuous selection of resistant mutants occurs mostly 
due to the use of third-generation cephalosporins (SADER et al. 2001, 
GALES et al. 2002). Indiscriminate use of antimicrobials is strongly 
associated to multidrug resistance, colonization, hospital outbreaks 
and severe infections due to ESBL-producing microorganisms. This 
is considered a public health problem, and not only institutional, once 
solutions and control depend on local policies for restricted antimicrobial 
use (BRADFORD 2001, PATERSON et al. 2000).
According to the infection control committee of the studied hospital, 
ESBL-producing enterobacteria represent a great challenge for the control 
of infection and colonization in the institution, especially in Intensive 
Care Units. Our results suggest that the problem of dissemination of 
resistant clones and genes in hospital environment can occur due to 
contact with healthcare workers or to the patient’s transferring between 
hospital units, once isolates presenting identical molecular patterns were 
observed in different wards, and some isolates showed patterns identical 
to the strain isolated from the hands of a nursing auxiliary in the institution 
(CASSETARI et al. 2009). Our data corroborate the importance of 
antibiotic use restriction and enhancement of prevention measures, 
mostly efficient hand-washing, contact isolation of colonized patients, 
appropriate cleansing and disinfection of materials and equipment, and 
monitoring of patients transference between hospital wards. Surveillance 
cultures are also of great value when appropriately applied (GUPTA et 
al. 2003).
In conclusion, several groups of bla genes were detected in clinical 
samples during one year in the studied institution, and further studies 
will be necessary to identify them precisely. Moreover, ESBL-Kp strains 
with unrelated molecular patterns carried bla genes located exclusively 
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in mobile elements, suggesting horizontal gene transfer between isolates. 
On the other hand, similar and/or identical ESBL-Kp according to PFGE 
were disseminated among several hospital wards, suggesting spread in 
hospital environment.
RESUMO
Beta-lactamases de espectro estendido em Enterobacteriaceae 
isoladas de Hospital Público no Brasil
Beta-lactamases de espectro estendido (ESBL) em enterobactérias 
são reconhecidas mundialmente como um grande problema hospitalar. 
Neste estudo, 127 Enterobacteriaceae produtoras de ESBL isoladas 
por um ano, de pacientes internados e ambulatoriais de um hospital 
público de ensino em São Paulo, Brasil, foram submetidas à análise 







. Dos 127 isolados, 96 (75,6%) K. pneumoniae, 12 (9,3%) 
E. coli, 8 (6,2%) M. morganii, 3 (2,3%) Proteus mirabilis, 2 (1,6%) 
Klebsiella oxytoca, 2 (1,6%) Providencia rettgeri, 2 (1,6%) Providencia 
stuartti, 1 (0,8%) Enterobacter aerogenes e 1 (0,8%) Enterobacter 







 foram detectados em 63%, 17,3% e 33,9% das cepas, 
respectivamente. A genotipagem de K. pneumoniae por eletroforese em 
campo pulsado revelou quatro padrões moleculares principais e 29 perfis 
não relacionados. Os resultados da PCR demonstraram alta variedade 
de grupos de ESBL entre as cepas, em nove espécies diferentes. Os 
resultados sugerem a disseminação de genes de resistência entre cepas 
geneticamente diferentes de K. pneumoniae produtoras de ESBL em 
algumas unidades do hospital, e também que algumas cepas fortemente 
relacionadas foram identificadas em unidades hospitalares diferentes, 
sugerindo disseminação clonal no ambiente da instituição.
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